Effects of histone acetyltransferase inhibitors on L-DOPA-induced dyskinesia in a murine model of Parkinson's disease.

Ryu, Young-Kyoung

Effects of histone acetyltransferase inhibitors on L-DOPA-induced dyskinesia in a murine model of Parkinson's disease. [electronic resource] - Journal of neural transmission (Vienna, Austria : 1996) 09 2018 - 1319-1331 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1435-1463

10.1007/s00702-018-1902-4 doi


Anacardic Acids--pharmacology
Animals
Antiparkinson Agents--toxicity
Curcumin--pharmacology
Cytoskeletal Proteins--biosynthesis
Drug Evaluation, Preclinical
Dyskinesia, Drug-Induced--drug therapy
Enzyme Inhibitors--pharmacology
Fos-Related Antigen-2--biosynthesis
Gene Expression Regulation--drug effects
Histone Acetyltransferases--antagonists & inhibitors
Histone Code--drug effects
Levodopa--toxicity
MAP Kinase Signaling System--drug effects
Male
Mice
Mice, Inbred C57BL
Nerve Tissue Proteins--biosynthesis
Oxidopamine--toxicity
Parkinsonian Disorders--drug therapy
Proto-Oncogene Proteins c-fos--biosynthesis
Specific Pathogen-Free Organisms
Substantia Nigra--drug effects
Terpenes--pharmacology